NLM Digital Collections

Search

Start Over Formats Text ✖Remove constraint Formats: Text Publication Year 2020 to 2021 ✖Remove constraint Publication Year: <span class="from" data-blrl-begin="2020">2020</span> to <span class="to" data-blrl-end="2021">2021</span>

1331. Treatments for anemia in chronic kidney disease: effectiveness and value : final evidence report

Author(s):
Mustafa, Reem A., author
Fox, Grace, (Of Institute for Clinical and Economic Review), author
Campbell, Jonathan D., author
Agboola, Foluso, author
Pearson, Steven D., author
Rind, David M., author
Bloudek, Lisa, author
Carlson, Josh J., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, March 5, 2021
Subject(s):
Glycine -- analogs & derivatives
Hematinics -- therapeutic use
Isoquinolines -- therapeutic use
Hypoxia-Inducible Factor-Proline Dioxygenases -- antagonists & inhibitors
Anemia, Iron-Deficiency -- drug therapy
Renal Insufficiency, Chronic -- complications
Renal Insufficiency, Chronic -- drug therapy
Treatment Outcome
United States

1332. Bempedoic acid and inclisiran for patients with heterozygous familial hypercholesterolemia and for secondary prevention of ASCVD: Effectiveness and value : final report

Author(s):
Lin, Grace A., author
Jih, Jane, author
Agboola, Foluso, author
Peason, Steven D., author
Kazi, Dhruv S., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, March 2, 2021
Subject(s):
Anticholesteremic Agents -- therapeutic use
Atherosclerosis -- prevention & control
ATP Citrate (pro-S)-Lyase -- antagonists & inhibitors
Dicarboxylic Acids -- therapeutic use
Fatty Acids
Hyperlipoproteinemia Type II -- drug therapy
RNA, Small Interfering
Secondary Prevention
Treatment Outcome
Drug Therapy Combination
Ezetimibe -- therapeutic use
United States